{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:54:57Z","timestamp":1760147697638,"version":"build-2065373602"},"reference-count":131,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T00:00:00Z","timestamp":1677196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Following reports of the first human SARS-CoV2 infection in December 2019 from Wuhan Province, China, there was such rapid spread that by March 2021, the World Health Organization (WHO) had declared a pandemic. Over 6.5 million people have died from this infection worldwide, although this is most likely an underestimate. Until vaccines became available, mortality and severe morbidity were costly in terms of life lost as well as the cost of supporting the severely and acutely ill. Vaccination changed the landscape, and following worldwide adoption, life has gradually been returning to normal. The speed of production of the vaccines was unprecedented and undoubtedly ushered in a new era in the science of fighting infections. The developed vaccines were on the already known platforms for vaccine delivery: inactivated virus, virus vector, virus-like particles (VLP) subunit, DNA and mRNA. The mRNA platform was used for the first time to deliver vaccines to humans. An understanding of these platforms and the pros and cons of each are important for clinicians who are often challenged by the recipients on the advantages and risks of these vaccines. These vaccines have so far and reassuringly been shown to be safe in reproduction (with no effect on gametes) and pregnancy (not associated with congenital malformations). However, safety remains paramount and continuing vigilance is critical, especially against rare fatal complications such as vaccine-induced thrombocytopenia and myocarditis. Finally, the waning immunity months after vaccination means repeated immunisation is likely to be ongoing, but just how often and how many such revaccinations should be recommended remains uncertain. Research into other vaccines and alternate delivery methods should continue as this infection is likely to be around for a long time.<\/jats:p>","DOI":"10.3390\/v15030621","type":"journal-article","created":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T04:05:40Z","timestamp":1677470740000},"page":"621","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Immunisation against COVID-19 in Pregnancy and of Women Planning Pregnancy"],"prefix":"10.3390","volume":"15","author":[{"given":"Justin C.","family":"Konje","sequence":"first","affiliation":[{"name":"Feto-Maternal Centre Al Markhiya, Doha P.O. Box 34181, Qatar"},{"name":"Obstetrics and Gynecology Department, Weill Cornell Medicine Qatar, Doha P.O. Box 24144, Qatar"},{"name":"Obstetrics and Gynaecology, Department of Health Sciences, University of Leicester, Leicester LE2 7LX, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariam","family":"Al Beloushi","sequence":"additional","affiliation":[{"name":"Women\u2019s Wellness and Research Centre, Hamad Medical Corporation, Doha P.O. Box 3050, Qatar"},{"name":"Department of Obstetrics and Gynaecology, Qatar University, Doha P.O. Box 2713, Qatar"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Badreldeen","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Feto-Maternal Centre Al Markhiya, Doha P.O. Box 34181, Qatar"},{"name":"Obstetrics and Gynecology Department, Weill Cornell Medicine Qatar, Doha P.O. Box 24144, Qatar"},{"name":"Department of Obstetrics and Gynaecology, Qatar University, Doha P.O. Box 2713, Qatar"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejogrb.2021.06.001","article-title":"Severe acute respiratory syndrome (SARS) coronavirus-2 infection (COVID-19) in pregnancy\u2014An overview","volume":"263","author":"Hamad","year":"2021","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Bio."},{"key":"ref_2","unstructured":"WHO (2020). WHO Director-General\u2019s Opening Remarks at the Media Briefing on COVID-19\u201411 March 2020."},{"key":"ref_3","unstructured":"(2022, September 24). Available online: https:\/\/coronavirus.jhu.edu\/map.html."},{"key":"ref_4","first-page":"181","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","author":"Cui","year":"2019","journal-title":"Nat. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1128\/MMBR.69.4.635-664.2005","article-title":"Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus","volume":"69","author":"Weiss","year":"2005","journal-title":"Microbiol. Mol. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1128\/JVI.02361-06","article-title":"Biologic, antigenic, and full-length genomic characterization of a bovine-like coronavirus isolated from a giraffe","volume":"81","author":"Hasoksuz","year":"2007","journal-title":"J. Virol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1086\/420743","article-title":"Severe acute respiratory syndrome","volume":"38","author":"Christian","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of SARS-CoV-2 by full length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.cmi.2020.04.023","article-title":"COVID-19 pandemic\u2014A focused review for clinicians","volume":"26","author":"Cevik","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijsu.2020.07.032","article-title":"A comparative overview of COVID-19, MERS and SARS: Review article","volume":"81","author":"Liu","year":"2020","journal-title":"Int. J. Surg."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"m3320","DOI":"10.1136\/bmj.m3320","article-title":"Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: Living systematic review and meta- analysis","volume":"370","author":"Allotey","year":"2020","journal-title":"BMJ"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1080\/21645515.2021.1911204","article-title":"COVID-19 vaccine platforms: Delivering on promise?","volume":"17","author":"Verdecia","year":"2021","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41541-020-0159-8","article-title":"The promise of mRNA vaccines: A biotech and industrial perspective","volume":"5","author":"Jackoson","year":"2020","journal-title":"NPJ Vaccines"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1521-4141(200001)30:1<1::AID-IMMU1>3.0.CO;2-#","article-title":"In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies","volume":"30","author":"Hoerr","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1182\/blood-2006-07-033258","article-title":"Immunostimulatory RNA oligonucleotides trigger an antigen-specific cytotoxic T-cell and IgG2a response","volume":"109","author":"Bourquin","year":"2007","journal-title":"Blood"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nature10072","article-title":"Detection of prokar- yotic mRNA signifies microbial viability and promotes immunity","volume":"22","author":"Sander","year":"2011","journal-title":"Nature"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.4049\/jimmunol.165.8.4710","article-title":"HIV gag mRNA transfection of dendritic cells (DC) delivers encoded antigen to MHC class I and II molecules, causes DC maturation, and induces a potent human in vitro primary immune response","volume":"15","author":"Weissman","year":"2000","journal-title":"J. Immunol."},{"key":"ref_18","unstructured":"Warkentin, T.E., and Cuker, A. (2021, May 07). COVID-19, Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT), Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK570605\/."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/biot.201400390","article-title":"Large-scale adenovirus and poxvirus-vectored vaccine manufacturing to enable clinical trials","volume":"10","author":"Kallel","year":"2015","journal-title":"Biotechnol. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.vaccine.2008.12.038","article-title":"No evidence of an increase of bacterial and viral infections following measles, mumps and rubella vaccine","volume":"25","author":"Stowe","year":"2009","journal-title":"Vaccine"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.coi.2011.03.006","article-title":"Viral vectors as vaccine platforms: Deployment in sight","volume":"23","author":"Rollier","year":"2011","journal-title":"Curr. Opin. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.4161\/hv.29594","article-title":"Pre-existing immunity against Ad vectors: Humoral, cellular, and innate response, what\u2019s important?","volume":"10","author":"Kobinger","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/21655979.2016.1191707","article-title":"Recent advances in the production of recombinant subunit vaccines in Pichia pastoris","volume":"7","author":"Wang","year":"2016","journal-title":"Bioengineered"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1099\/jmm.0.039180-0","article-title":"The current challenges for vaccine development","volume":"61","author":"Oyston","year":"2012","journal-title":"J. Med. Microbiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"C4591001 Clinical Trial Group. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.15585\/mmwr.mm7032e4","article-title":"Use of COVID-19 vaccines after reports of adverse events among adult recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 vaccines (Pfizer-BioNTech and moderna): Update from the Advisory Committee on Immunization Practices\u2014United States, July 2021","volume":"70","author":"Rosenblum","year":"2021","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.reprotox.2021.05.007","article-title":"Lack of effects on female fertility and prenatal and postnatal offspring development in rats with BNT162b2, a mRNA-based COVID-19 vaccine","volume":"103","author":"Bowman","year":"2021","journal-title":"Reprod. Toxicol."},{"key":"ref_28","unstructured":"American College of Obstetricians and Gy-Necologists (2022, February 07). COVID-19 FAQs for Obstetrician-Gynecologists, Obstetrics. Available online: https:\/\/www.acog.org\/clinical-information\/physician-faqs\/covid-19-faqs-for-ob-gyns-ob-stetrics."},{"key":"ref_29","unstructured":"American College of Obstetricians and Gynecologists (2022, February 07). COVID-19 Vaccination Considerations for Obstetrice-Gynecologic Care. Available online: https:\/\/www.acog.org\/clinical\/clinical-guidance\/practice-advisory\/articles\/2020\/12\/covid-19-vaccination-considerations-for-obstetricgynecologic-care."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_31","unstructured":"Southwestern Vaccine Science UT, Review Committee (2022, October 23). Scientific Review of Moderna COVID-19 Vaccine (mRNA-1273). Available online: https:\/\/AOG.0000000000004438www.utsouthwestern.edu\/covid-19\/assets\/moderna-review.pdf."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19","volume":"384","author":"Sadoff","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_33","unstructured":"U.S. Food and Drug Administration (2022, October 23). Emergency Use Authorization (EUA) of the Janssen COVID-19 Vaccine to Prevent Coronavirus Disease 2019 (COVID-19), Available online: https:\/\/www.fda.gov\/media\/146304\/download."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2, an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.reprotox.2021.07.010","article-title":"Developmental and reproductive safety of AZD1222 (ChAdOx1 nCoV-19) in mice","volume":"104","author":"Stebbings","year":"2021","journal-title":"Reprod. Toxicol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/AOG.0000000000004438","article-title":"Antibody response to coronavirus disease 2019 (COVID-19) messenger RNA vaccination in pregnant women and transplacental passage into cord blood","volume":"138","author":"Prabhu","year":"2021","journal-title":"Obstet. Gynecol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.2021.7563","article-title":"Immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women","volume":"325","author":"Collier","year":"2021","journal-title":"JAMA"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"68.e1","DOI":"10.1016\/j.ajog.2022.07.014","article-title":"COVID-19 booster dose induces robust antibody response in pregnant, lactating, and nonpregnant women","volume":"228","author":"Atyeo","year":"2023","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"264","DOI":"10.15585\/mmwr.mm7107e3","article-title":"Effectiveness of Maternal Vaccination with mRNA COVID-19 Vaccine During Pregnancy Against COVID-19-Associated Hospitalization in Infants Aged <6 Months\u201417 States, July 2021\u2013January 2022","volume":"18","author":"Halasa","year":"2022","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e069741","DOI":"10.1136\/bmj-2021-069741","article-title":"COVID-19 vaccination in pregnancy","volume":"378","author":"Badell","year":"2022","journal-title":"BMJ"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Shen, C.J., Fu, Y.C., Lin, Y.P., Shen, C.F., Sun, D.J., Chen, H.Y., and Cheng, C.M. (2022). Evaluation of Transplacental Antibody Transfer in SARS-CoV-2-Immunized Pregnant Women. Vaccines, 10.","DOI":"10.3390\/vaccines10010101"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e154834","DOI":"10.1172\/JCI154834","article-title":"Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine","volume":"131","author":"Beharier","year":"2021","journal-title":"J. Clin. Invest."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/ijgo.14014","article-title":"The association of maternal SARS-CoV-2 vaccination-to-delivery interval and the levels of maternal and cord blood antibodies","volume":"156","author":"Amikam","year":"2022","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/uog.23729","article-title":"Short-term outcome of pregnant women vaccinated with BNT162b2 mRNA COVID-19 vaccine","volume":"58","author":"Regev","year":"2021","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1038\/s41372-021-01216-1","article-title":"Titers of SARS-CoV-2 antibodies in cord blood of neonates whose mothers contracted SARS-CoV-2 (COVID-19) during pregnancy and in those whose mothers were vaccinated with mRNA to SARS-CoV-2 during pregnancy","volume":"41","author":"Lopian","year":"2021","journal-title":"J. Perinatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1001\/jamapediatrics.2021.5683","article-title":"Maternal and Neonatal SARS-CoV-2 Immunoglobulin G Antibody Levels at Delivery After Receipt of the BNT162b2 Messenger RNA COVID-19 Vaccine During the Second Trimester of Pregnancy","volume":"176","author":"Kugelman","year":"2022","journal-title":"JAMA Pediatr."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"100492","DOI":"10.1016\/j.ajogmf.2021.100492","article-title":"Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies among parturient women treated with BNT162b2 messenger RNA vaccine during pregnancy","volume":"4","author":"Nir","year":"2022","journal-title":"Am. J. Obstet Gynecol. MFM"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1093\/cid\/ciab266","article-title":"27 Efficient Maternofetal Transplacental Transfer of Anti- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Antibodies After Antenatal SARS-CoV-2 BNT162b2 Messenger RNA Vaccination","volume":"73","author":"Rottenstreich","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e603","DOI":"10.1093\/cid\/ciac135","article-title":"The effect of gestational age at BNT162b2 mRNA vaccination on maternal and neonatal SARS-CoV-2 antibody levels","volume":"75","author":"Rottenstreich","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/1471-0528.16941","article-title":"COVID-19 vaccination during the third trimester of pregnancy: Rate of vaccination and maternal and neonatal outcomes, a multicentre retrospective cohort study","volume":"129","author":"Rottenstreich","year":"2022","journal-title":"BJOG"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"eabi8631","DOI":"10.1126\/scitranslmed.abi8631","article-title":"COVID-19 mRNA vaccines drive differential antibody Fc-functional profiles in pregnant, lactating, and nonpregnant women","volume":"13","author":"Atyeo","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ajog.2021.03.035","article-title":"Cord blood antibodies following maternal coronavirus disease 2019 vaccination during pregnancy","volume":"225","author":"Mithal","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/AOG.0000000000004457","article-title":"Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination in Pregnancy: Measures of Immunity and Placental Histopathology","volume":"138","author":"Shanes","year":"2021","journal-title":"Obstet. Gynecol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"303.e1","DOI":"10.1016\/j.ajog.2021.03.023","article-title":"Coronavirus disease 2019 vaccine response in pregnant and lactating women: A cohort study","volume":"225","author":"Gray","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"100481","DOI":"10.1016\/j.ajogmf.2021.100481","article-title":"High antibody levels in cord blood from pregnant women vaccinated against COVID-19","volume":"3","author":"Trostle","year":"2021","journal-title":"Am. J. Obstet. Gynecol. MFM"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Citu, I.M., Citu, C., Gorun, F., Sas, I., Tomescu, L., Neamtu, R., Motoc, A., Gorum, A.M., Burlea, B., and Brastosin, F. (2022). Immunogenicity Following Administration of BNT162b2 and Ad26.COV2.S COVID-19 Vaccines in the Pregnant Population during the Third Trimester. Viruses, 14.","DOI":"10.3390\/v14020307"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ajog.2021.10.006","article-title":"Newborns\u2019 passive humoral SARS-CoV-2 immunity following heterologous vaccination of the mother during pregnancy","volume":"226","author":"Gloeckner","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/AOG.0000000000004693","article-title":"Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose with Maternal and Umbilical Cord Antibody Levels at Delivery","volume":"139","author":"Yang","year":"2022","journal-title":"Obstet. Gynecol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00431-019-03563-w","article-title":"Vaccination during pregnancy: Current and possible future recommendations","volume":"179","author":"Maertens","year":"2020","journal-title":"Eur. J. Pediatr."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa2119451","article-title":"COVID-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant","volume":"21","author":"Andrews","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_61","unstructured":"The Institute for Health Metrics and Evaluation (IHME) (2022, May 17). COVID-19 Vaccine Efficacy Summary. Available online: https:\/\/www.healthdata.org\/covid\/covid-19-vaccine-efficacy-summary."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1038\/s41591-021-01490-8","article-title":"Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy","volume":"27","author":"Dagan","year":"2021","journal-title":"Nat. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1056\/NEJMoa2200797","article-title":"Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar","volume":"386","author":"Chemaitelly","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Noureddine, F.Y., Chakkour, M., El Roz, A., Reda, J., Al Sahily, R., Assi, A., Joma, M., Salami, H., Hashem, S.J., and Harb, B. (2021). The Emergence of SARS-CoV-2 Variant(s) and Its Impact on the Prevalence of COVID-19 Cases in the Nabatieh Region, Lebanon. Med. Sci., 9.","DOI":"10.1101\/2021.04.08.21255005"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"317","DOI":"10.14740\/jocmr4518","article-title":"Review of COVID-19 Variants and COVID-19 Vaccine Efficacy: What the Clinician Should Know?","volume":"13","author":"Vasireddy","year":"2021","journal-title":"J. Clin. Med. Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1001\/jama.2021.15494","article-title":"Spontaneous Abortion Following COVID-19 Vaccination During Pregnancy","volume":"326","author":"Kharbanda","year":"2021","journal-title":"JAMA"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"26","DOI":"10.15585\/mmwr.mm7101e1","article-title":"Receipt of COVID-19 Vaccine During Pregnancy and Preterm or Small-for-Gestational-Age at Birth; Eight Integrated Health Care Organizations: United","volume":"7","author":"Lipkind","year":"2022","journal-title":"R Morb Mortal Wkly Rep."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/AOG.0000000000004621","article-title":"Maternal Outcomes After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Vaccinated Compared with Unvaccinated Pregnant Patients","volume":"139","author":"Morgan","year":"2022","journal-title":"Obstet. Gynecol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1001\/jamapediatrics.2022.0164","article-title":"Association of COVID-19 Vaccination During Early Pregnancy with Risk of Congenital Fetal Anomalies","volume":"176","author":"Ruderman","year":"2022","journal-title":"JAMA Pediatr."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1056\/NEJMoa2104983","article-title":"Preliminary Findings of mRNA COVID-19 Vaccine Safety in Pregnant Persons","volume":"384","author":"Shimabukuro","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"100467","DOI":"10.1016\/j.ajogmf.2021.100467","article-title":"Pregnancy and birth outcomes after SARS-CoV-2 vaccination in pregnancy","volume":"3","author":"Theiler","year":"2021","journal-title":"Am. J. Obstet. Gynecol. MFM"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"100464","DOI":"10.1016\/j.ajogmf.2021.100464","article-title":"COVID-19 vaccination in pregnancy: Early experience from a single institution","volume":"3","author":"Trostle","year":"2021","journal-title":"Am. J. Obstet. Gynecol. MFM"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1056\/NEJMc2113891","article-title":"Receipt of mRNA COVID-19 Vaccines and Risk of Spontaneous Abortion","volume":"385","author":"Zauche","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"6535","DOI":"10.1016\/j.vaccine.2021.09.043","article-title":"Early exploration of COVID-19 vaccination safety and effectiveness during pregnancy: Interim descriptive data from a prospective observational study","volume":"39","author":"Bleicher","year":"2021","journal-title":"Vaccine"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Dick, A., Rosenbloom, J.I., Gutman-Ido, E., Lessans, N., Cahen-Peretz, A., and Chill, H.H. (2022). Safety of SARS-CoV-2 vaccination during pregnancy-obstetric outcomes from a large cohort study. BMC Pregnancy Childbirth, 22.","DOI":"10.1186\/s12884-022-04505-5"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1001\/jamapediatrics.2022.0001","article-title":"Association of BNT162b2 COVID-19 Vaccination During Pregnancy with Neonatal and Early Infant Outcomes","volume":"176","author":"Goldshtein","year":"2022","journal-title":"JAMA Pediatr."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.1016\/j.vaccine.2021.09.012","article-title":"Prenatal maternal COVID-19 vaccination and pregnancy outcomes","volume":"39","author":"Wainstock","year":"2021","journal-title":"Vaccine"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/jama.2022.3271","article-title":"Association of SARS-CoV-2 Vaccination During Pregnancy with Pregnancy Outcomes","volume":"327","author":"Magnus","year":"2022","journal-title":"JAMA"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1056\/NEJMc2114466","article-title":"COVID-19 Vaccination during Pregnancy and First-Trimester Miscarriage","volume":"385","author":"Magnus","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1001\/jama.2022.4255","article-title":"Association of COVID-19 Vaccination in Pregnancy with Adverse Peripartum Outcomes","volume":"327","author":"Fell","year":"2022","journal-title":"JAMA"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/S1473-3099(22)00426-1","article-title":"For the Canadian Immunization Research Network. Safety of COVID-19 vaccines in pregnancy: A Canadian National Vaccine Safety (CANVAS) network cohort study","volume":"22","author":"Sadarangani","year":"2022","journal-title":"Lancet Infec. Dis."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"236.e1","DOI":"10.1016\/j.ajog.2021.08.007","article-title":"COVID-19 vaccination during pregnancy: Coverage and safety","volume":"226","author":"Blakeway","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/07853890.2017.1421320","article-title":"Maternal immunization: Where are we now and how to move forward?","volume":"50","author":"Vojtek","year":"2018","journal-title":"Ann. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1001\/jama.2021.1658","article-title":"COVID-19 Vaccination in Pregnant and Lactating Women","volume":"325","author":"Adhikari","year":"2021","journal-title":"JAMA"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Zdanowski, W., and Wasniewski, T. (2021). Evaluation of SARS-CoV-2 Spike Protein Antibody Titers in Cord Blood after COVID-19 Vaccination during Pregnancy in Polish Healthcare Workers: Preliminary Results. Vaccines, 9.","DOI":"10.22541\/au.162023176.65260617\/v1"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1055\/a-1721-4908","article-title":"Assessment of Neonatal Cord Blood SARS-CoV-2 Antibodies after COVID-19 Vaccination in Pregnancy: A Prospective Cohort Study","volume":"82","author":"Sourouni","year":"2022","journal-title":"Geburtshilfe Frauenheilkd."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Popescu, D.-E., C\u00eetu, C., Jura, A.M.C., Lungu, N., Navolan, D., Craina, M., Semenescu, A.M., Gorum, F., Jura, M.-A., and Belengeanu, V. (2022). The Benefits of Vaccination against SARS-CoV-2 during Pregnancy in Favor of the Mother\/Newborn Dyad. Vaccines, 10.","DOI":"10.3390\/vaccines10060848"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/jamapediatrics.2021.0043","article-title":"Can we protect pregnant women and young infants from COVID-19 through maternal immunization","volume":"175","author":"Munoz","year":"2021","journal-title":"JAMA Pediatr."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cmi.2021.10.003","article-title":"Timing of SARS-CoV-2 vaccination during the third trimester of pregnancy and transplacental antibody transfer: A prospective cohort study","volume":"28","author":"Rottenstreich","year":"2022","journal-title":"Clinic. Microbiol. Infect."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1038\/s41467-022-31169-8","article-title":"Maternal immune response and placental antibody transfer after COVID-19 vaccination across trimester and platforms","volume":"13","author":"Atyeo","year":"2022","journal-title":"Nat. Comm."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41541-021-00370-z","article-title":"Codominant IgG and IgA expression with minimal vaccine mRNA in milk of BNT162b2 vaccinees","volume":"6","author":"Low","year":"2021","journal-title":"NPJ Vaccines."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1001\/jama.2021.5782","article-title":"SARS-CoV-2\u2013Specific Antibodies in Breast Milk After COVID-19 Vaccination of Breastfeeding Women","volume":"325","author":"Perl","year":"2021","journal-title":"JAMA"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1177\/08903344211030168","article-title":"SARS-CoV-2 antibodies detected in mother\u2019s milk post-vaccination","volume":"37","author":"Baird","year":"2021","journal-title":"J. Hum. Lact."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1089\/bfm.2021.0353","article-title":"Antibodies Against SARS-CoV-2 in Human Breast Milk After Vaccination: A Systematic Review and Meta-Analysis","volume":"17","author":"Whited","year":"2022","journal-title":"Breastfeed. Med."},{"key":"ref_95","first-page":"e03192-20","article-title":"Characterization of SARS-CoV-2 RNA, Antibodies, and Neutralizing Capacity in Milk Produced by Women with COVID-19","volume":"12","author":"Pace","year":"2021","journal-title":"Epidemiology"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/jamapediatrics.2021.4897","article-title":"Association of Human Milk Antibody Induction, Persistence, and Neutralizing Capacity with SARS-CoV-2 Infection vs mRNA Vaccination","volume":"176","author":"Young","year":"2022","journal-title":"JAMA Pediatrics."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"e2021054260","DOI":"10.1542\/peds.2021-054260","article-title":"Human milk SARS-CoV-2 antibodies up to 6 months after vaccination","volume":"149","author":"Perez","year":"2022","journal-title":"Pediatrics"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Rodriguez-Garcia, M., Biswas, N., Patel, M.V., Barr, F.D., Crist, S.G., Ochsenbauer, C., Fahey, J.V., and Wira, C.R. (2013). Estradiol reduces susceptibility of CD4+ T cells and macrophages to HIV-infection. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0062069"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Goad, J., Rudolph, J., and Rajkovic, A. (2020). Female reproductive tract has low concentration of SARS-CoV2 receptors. PLoS ONE, 15.","DOI":"10.1101\/2020.06.20.163097"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/aji.13351","article-title":"Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its effect on gametogenesis and early pregnancy","volume":"84","author":"Singh","year":"2020","journal-title":"Am. J. Reprod. Immunol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ajog.2020.03.021","article-title":"Coronavirus disease 2019 (COVID-19) pandemic and pregnancy","volume":"222","author":"Dashraath","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Wang, Z., and Xu, X. (2020). scRNA-seq profiling of human testes reveals the presence of the ACE2 receptor, a target for SARS-CoV-2 infection in spermatogonia, Leydig and Sertoli cells. Cells, 9.","DOI":"10.20944\/preprints202002.0299.v1"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/andr.12825","article-title":"SARS-CoV-2 presence in seminal fluid: Myth or reality","volume":"9","author":"Paoli","year":"2021","journal-title":"Andrology"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"154252","DOI":"10.1016\/j.metabol.2020.154252","article-title":"Testosterone, a key hormone in the context of COVID-19 pandemic [Commentary]","volume":"108","author":"Pozzilli","year":"2020","journal-title":"Metabolism"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1095\/biolreprod.105.044776","article-title":"Orchitis: A complication of severe acute respiratory syndrome (SARS)","volume":"74","author":"Xu","year":"2006","journal-title":"Biol. Reprod."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e13791","DOI":"10.1111\/and.13791","article-title":"Impact of COVID-19 and other viruses on reproductive health","volume":"52","author":"Batiha","year":"2020","journal-title":"Andrologia"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"e208292","DOI":"10.1001\/jamanetworkopen.2020.8292","article-title":"Clinical characteristics and results of semen tests among men with coronavirus disease 2019","volume":"3","author":"Li","year":"2020","journal-title":"JAMA Network Open"},{"key":"ref_108","unstructured":"(2021, April 27). A Guide to WHO\u2019s Guidance on COVID-19 [Internet]. Available online: https:\/\/www.who.int\/news-room\/feature-stories\/detail\/a-guide-to-who-s-guidance."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.1002\/jmv.27971","article-title":"Investigation of the effect of COVID-19 on sperm count, motility and morphology","volume":"94","author":"Aksak","year":"2022","journal-title":"J. Med. Virol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"110","DOI":"10.21037\/tau-21-935","article-title":"Rapid impact of COVID-19 infection on semen quality: A case report","volume":"11","author":"Gharagozloo","year":"2022","journal-title":"Transl. Androl. Urol."},{"key":"ref_111","unstructured":"American College of Obstetricians and Gynecologists (2021, April 27). COVID-19 FAQs for Obstetrician\u2013Gynecologists, Gynecology. COVID-19 FAQs. Washington, DC: ACOG. 30 May 2020. Available online: https:\/\/www.acog.org\/clinical-information\/physician-faqs\/covid19-faqs-for-ob-gyns-gynecology."},{"key":"ref_112","unstructured":"Royal College of Obstetricians and Gynecologists (2021, April 27). Corona Virus (COVID-19) and gynaecological services. Available online: https:\/\/www.rcog.org.uk\/en\/guidelines-research-services\/coronavirus-covid-19-pregnancy-and-womens-health\/coronavirus-covid-19-and-gynaecological-services\/."},{"key":"ref_113","unstructured":"International Federation of Gynecology and Obstetrics (2021, April 27). COVID-19 (Corona Virus) Statement. FIGO.2020. Available online: https:\/\/www.figo.org\/covid-19-coronavirus-statement."},{"key":"ref_114","first-page":"3","article-title":"Assisted reproduction and COVID-19, a joint statement of ASRM, ESHRE and IFFS","volume":"1","author":"Veiga","year":"2020","journal-title":"Hum. Reprod. Open"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.rbmo.2020.04.003","article-title":"COVID-19 and ART: The view of the Italian Society of Fertility and Sterility and Reproductive Medicine","volume":"40","author":"Vaiarelli","year":"2020","journal-title":"Reprod. Biomed. Online."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/jama.2021.9976","article-title":"Sperm parameters before and after COVID-19 mRNA vaccination","volume":"326","author":"Gonzalez","year":"2021","journal-title":"JAMA"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"hoab016","DOI":"10.1093\/hropen\/hoab016","article-title":"Joint IFFS\/ESHRE statement on COVID-19 vaccination for pregnant women and those considering pregnancy","volume":"2","author":"Ory","year":"2021","journal-title":"Hum. Reprod. Open."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12958-021-00757-6","article-title":"Does mRNA SARS-CoV-2 vaccine influence patients\u2019 performance during IVF-ET cycle?","volume":"19","author":"Haas","year":"2021","journal-title":"Reprod. Biol. Endocrinol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1093\/humrep\/deab182","article-title":"Klement Ovarian follicular function is not altered by SARS\u2013CoV-2 infection or BNT162b2 mRNA COVID-19 vaccination","volume":"36","author":"Bentov","year":"2021","journal-title":"Hum. Reprod."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.1016\/j.vaccine.2022.09.019","article-title":"The impact of COVID-19 vaccines on fertility\u2014A systematic review and meta-analysis","volume":"40","author":"Petrella","year":"2022","journal-title":"Vaccine"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"e2121310","DOI":"10.1001\/jamanetworkopen.2021.21310","article-title":"Short-term Reactions among Pregnant and Lactating Individuals in the First Wave of the COVID-19 Vaccine Rollout","volume":"4","author":"Kachikis","year":"2021","journal-title":"JAMA Netw. Open."},{"key":"ref_122","unstructured":"(2022, October 17). Available online: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/expect\/after.html."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0140-6736(20)31970-X","article-title":"Safety and efficacy of the Russian COVID-19 vaccine: More information needed\u2014Authors\u2019 reply","volume":"396","author":"Logunov","year":"2020","journal-title":"Lancet"},{"key":"ref_124","first-page":"73","article-title":"Vaccine-induced immune thrombotic thrombocytopenia","volume":"9","author":"Kloff","year":"2021","journal-title":"Lancet Haematol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"100057","DOI":"10.1016\/j.jacadv.2022.100057","article-title":"Cardiovascular Disease in Women Committee Cardiovascular Complications of Pregnancy\u2014Associated COVID-19 Infections","volume":"1","author":"Briller","year":"2022","journal-title":"JACC Adv."},{"key":"ref_126","unstructured":"Centers for Disease Control and Prevention (2022, May 18). COVID-19 Vaccines While Pregnant or Breastfeeding, Available online: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/recommendations\/pregnancy.html."},{"key":"ref_127","unstructured":"(2022, October 17). Society for Maternal-Fetal Medicine SMFM: Provider Considerations for Engaging in COVID-19 Vaccine Counseling with Pregnant and Lactating Patients. 1.11.2022 (Last Published 12.20.21). Available online: https:\/\/s3.amazonaws.com\/cdn.smfm.org\/media\/3290\/Provider_Considerations_for_Engaging_in_COVID_Vaccination_Considerations_1-11-22_%28final%29_KS.pdf."},{"key":"ref_128","unstructured":"(2022, October 17). Society for Maternal-Fetal Medicine SMFM: COVID-19 and Pregnancy: What Maternal-Fetal Medicine Subspecialists Need to Know. 3.2.22 (update of draft originally posted on 1.3.2022). Available online: https:\/\/s3.amazonaws.com\/cdn.smfm.org\/media\/3402\/COVID19-What_MFMs_need_to_know_revision_3-1-22_%28final%29.pdf."},{"key":"ref_129","unstructured":"(2021, March 22). Available online: https:\/\/www.acog.org\/clinical\/clinical-guidance\/practice-advisory\/articles\/2020\/12\/vaccinating-pregnant-and-lactating-patients-against-covid-19."},{"key":"ref_130","unstructured":"Royal College of Obstetricians and Gynaecologists (2022, October 17). Coronavirus (COVID-19) Infection in Pregnancy. Information for Healthcare Professionals. Version 15, Published Monday 7 March 2022. Available online: https:\/\/www.rcog.org.uk\/media\/xsubnsma\/2022-03-07-coronavirus."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3390\/covid2070063","article-title":"Risk Markers of COVID-19, a Study from South-Lebanon","volume":"2","author":"Chakkour","year":"2022","journal-title":"COVID"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/15\/3\/621\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:41:32Z","timestamp":1760121692000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/15\/3\/621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,24]]},"references-count":131,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["v15030621"],"URL":"https:\/\/doi.org\/10.3390\/v15030621","relation":{},"ISSN":["1999-4915"],"issn-type":[{"type":"electronic","value":"1999-4915"}],"subject":[],"published":{"date-parts":[[2023,2,24]]}}}